Literature DB >> 8416386

Theiler's virus infection of beta 2-microglobulin-deficient mice.

L Fiette1, C Aubert, M Brahic, C P Rossi.   

Abstract

Theiler's virus, a murine picornavirus, persists in the central nervous systems of susceptible mice and induces a chronic demyelinating disease. Susceptibility or resistance to this disease is controlled in part by the H2-D locus of the major histocompatibility complex (MHC). For this reason, it has been proposed that CD8+ class I-restricted cytotoxic T cells play a main role in the pathogenesis of this viral infection. We recently reported the existence of anti-virus CD8+ cytotoxic T cells in the course of Theiler's virus infection. In the present study, we examined the role of these effector cells in mice in which the beta 2-microglobulin gene had been disrupted. These mice fail to express class I MHC molecules and therefore lack CD8+ T cells. The mice are derived from a C57BL/6 x 129/Ola cross and are H-2b, a haplotype associated with resistance to Theiler's virus infection. beta 2-Microglobulin-deficient mice (beta 2m-/-mice) failed to clear the virus, developed demyelination, and, interestingly, did not succumb to early infection. These results demonstrate that CD8+ T cells are required to clear Theiler's virus infection. In contrast with a current hypothesis, they also demonstrate that CD8+ T cells are not major mediators of the demyelinating disease.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8416386      PMCID: PMC237400     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  27 in total

1.  The interaction of two groups of murine genes determines the persistence of Theiler's virus in the central nervous system.

Authors:  J F Bureau; X Montagutelli; S Lefebvre; J L Guénet; M Pla; M Brahic
Journal:  J Virol       Date:  1992-08       Impact factor: 5.103

2.  Theiler's virus infection in mice: an unusual biphasic disease process leading to demyelination.

Authors:  H L Lipton
Journal:  Infect Immun       Date:  1975-05       Impact factor: 3.441

3.  In vivo induction of H-2K/D antigens by recombinant interferon-gamma.

Authors:  F Momburg; N Koch; P Möller; G Moldenhauer; G J Hämmerling
Journal:  Eur J Immunol       Date:  1986-05       Impact factor: 5.532

Review 4.  Natural cell-mediated immunity.

Authors:  R B Herberman; H T Holden
Journal:  Adv Cancer Res       Date:  1978       Impact factor: 6.242

5.  Simultaneous in situ detection of viral RNA and antigens.

Authors:  M Brahic; A T Haase; E Cash
Journal:  Proc Natl Acad Sci U S A       Date:  1984-09       Impact factor: 11.205

6.  In vivo effects of anti-asialo GM1. I. Reduction of NK activity and enhancement of transplanted tumor growth in nude mice.

Authors:  S Habu; H Fukui; K Shimamura; M Kasai; Y Nagai; K Okumura; N Tamaoki
Journal:  J Immunol       Date:  1981-07       Impact factor: 5.422

7.  Contrasting effects of immunosuppression on Theiler's virus infection in mice.

Authors:  H L Lipton; C D Canto
Journal:  Infect Immun       Date:  1977-03       Impact factor: 3.441

8.  Partial suppression of Theiler's virus-induced demyelination in vivo by administration of monoclonal antibodies to immune-response gene products (Ia antigens).

Authors:  M Rodriguez; W P Lafuse; J Leibowitz; C S David
Journal:  Neurology       Date:  1986-07       Impact factor: 9.910

9.  Demyelinating lesions due to Theiler's virus are associated with ongoing central nervous system infection.

Authors:  M Chamorro; C Aubert; M Brahic
Journal:  J Virol       Date:  1986-03       Impact factor: 5.103

10.  Susceptibility of inbred mice to chronic central nervous system infection by Theiler's murine encephalomyelitis virus.

Authors:  H L Lipton; M C Dal Canto
Journal:  Infect Immun       Date:  1979-10       Impact factor: 3.441

View more
  67 in total

1.  Prevalent class I-restricted T-cell response to the Theiler's virus epitope Db:VP2121-130 in the absence of endogenous CD4 help, tumor necrosis factor alpha, gamma interferon, perforin, or costimulation through CD28.

Authors:  A J Johnson; M K Njenga; M J Hansen; S T Kuhns; L Chen; M Rodriguez; L R Pease
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

2.  Differences in avidity and epitope recognition of CD8(+) T cells infiltrating the central nervous systems of SJL/J mice infected with BeAn and DA strains of Theiler's murine encephalomyelitis virus.

Authors:  Bong-Su Kang; Michael A Lyman; Byung S Kim
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

3.  Preferential induction of protective T cell responses to Theiler's virus in resistant (C57BL/6 x SJL)F1 mice.

Authors:  Young-Hee Jin; Hyun Seok Kang; Mani Mohindru; Byung S Kim
Journal:  J Virol       Date:  2010-12-29       Impact factor: 5.103

4.  An early, abundant cytotoxic T-lymphocyte response against Theiler's virus is critical for preventing viral persistence.

Authors:  S Dethlefs; M Brahic; E L Larsson-Sciard
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

5.  Conditional Silencing of H-2Db Class I Molecule Expression Modulates the Protective and Pathogenic Kinetics of Virus-Antigen-Specific CD8 T Cell Responses during Theiler's Virus Infection.

Authors:  Zachariah P Tritz; Robin C Orozco; Courtney S Malo; Katayoun Ayasoufi; Cori E Fain; Roman H Khadka; Emma N Goddery; Lila T Yokanovich; Megan L Settell; Michael J Hansen; Fang Jin; Kevin D Pavelko; Larry R Pease; Aaron J Johnson
Journal:  J Immunol       Date:  2020-07-31       Impact factor: 5.422

Review 6.  Neuroimmune interactions in a model of multiple sclerosis.

Authors:  C Jane Welsh; Andrew J Steelman; Wentao Mi; Colin R Young; Ralph Storts; Thomas H Welsh; Mary W Meagher
Journal:  Ann N Y Acad Sci       Date:  2009-02       Impact factor: 5.691

7.  Gamma interferon is critical for resistance to Theiler's virus-induced demyelination.

Authors:  M Rodriguez; K Pavelko; R L Coffman
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

8.  Identification of a major T-cell epitope within VP3 amino acid residues 24 to 37 of Theiler's virus in demyelination-susceptible SJL/J mice.

Authors:  R L Yauch; K Kerekes; K Saujani; B S Kim
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

9.  FVB mice transgenic for the H-2Db gene become resistant to persistent infection by Theiler's virus.

Authors:  A Azoulay; M Brahic; J F Bureau
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

10.  Pro-inflammatory functions of astrocytes correlate with viral clearance and strain-dependent protection from TMEV-induced demyelinating disease.

Authors:  Pamela A Carpentier; Meghann Teague Getts; Stephen D Miller
Journal:  Virology       Date:  2008-03-04       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.